...
首页> 外文期刊>Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology >Responses to GHRH plus arginine test are more concordant with IGF-I circulating levels than responses to arginine and clonidine provocative tests
【24h】

Responses to GHRH plus arginine test are more concordant with IGF-I circulating levels than responses to arginine and clonidine provocative tests

机译:与对精氨酸和可乐定激发试验的反应相比,对GHRH加精氨酸试验的反应与IGF-I循环水平更为一致

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background/objective: Although pharmacological GH stimulation tests are still considered the gold standard for GH deficiency (GHD) diagnosis, they are burdened by poor specificity. The majority of children diagnosed as having GHD show normal GH responses when re-tested at the end of growth, thus questioning the initial diagnosis. We evaluated the concordance between IGF-I levels and GH responses to provocative tests. Methods: We analyzed 105 GHRH plus arginine tests, 79 arginine tests, and 124 clonidine tests performed in 192 short children. IGF-I levels ≤-2SD score (SDS) were considered suggestive for high likelihood of GHD. The percentage of positive and negative results for each test was determined and compared with IGF-I levels, clinical follow-up and response to therapy. Results: In children with IGF-I>-2SDS the arginine test showed a concordance rate of 6.9%, the clonidine test of 28.6%, and GHRH plus arginine test of 70%. In children with IGF-I≤-2SDS the concordance was 96.1%, 85.7%, and 46.4%, respectively. The overall concordance was 66.7% for GHRH plus arginine, 42.7% for clonidine, and 27.8% for arginine tests. Conclusion: Our results suggest that GHRH plus arginine test provides the best concordance with the assessment of IGF-I levels thus suggesting that the combination of the two procedures may significantly reduce the need of a second provocative test.
机译:背景/目的:尽管药理生长激素刺激试验仍被认为是诊断生长激素缺乏症(GHD)的金标准,但它们的特异性差。在生长末期重新测试时,大多数被诊断为GHD的儿童表现出正常的GH反应,因此对最初的诊断提出了质疑。我们评估了IGF-I水平与GH对刺激性试验的反应之间的一致性。方法:我们分析了192名矮小的儿童中进行的105 GHRH加精氨酸测试,79精氨酸测试和124可乐定测试。 IGF-I水平≤-2SD评分(SDS)被认为提示GHD的可能性很高。确定每个测试的阳性和阴性结果的百分比,并将其与IGF-I水平,临床随访和对治疗的反应进行比较。结果:IGF-I> -2SDS患儿的精氨酸检验一致性率为6.9%,可乐定检验为28.6%,GHRH加精氨酸检验为70%。 IGF-I≤-2SDS患儿的一致性分别为96.1%,85.7%和46.4%。 GHRH加精氨酸的总体一致性为66.7%,可乐定的总体一致性为42.7%,精氨酸测试的总体一致性为27.8%。结论:我们的结果表明,GHRH加精氨酸测试与IGF-I水平的评估具有最佳的一致性,因此表明这两种方法的结合可以显着减少第二次激发性测试的需要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号